This technology is a customizable, fully synthetic hydrogel made from self-assembling nucleopeptides, designed to mimic the natural cell environment, support stem cell growth, deliver growth factors and nucleic acids, and replace animal-derived cell culture matrices.
The field of advanced cell culture, particularly involving human induced pluripotent stem cells, relies heavily on three-dimensional extracellular matrix substrates to support cell growth, differentiation, and tissue modeling. There is a critical need for highly defined, biocompatible, and tunable culture environments that can accurately mimic the native extracellular matrix. Researchers require reliable substrates that provide structural support while enabling the precise regulation of cellular behaviors. Developing fully synthetic platforms that support cell adhesion and viability is essential to advance regenerative medicine, disease modeling, and translational research.
Despite this growing need, current gold-standard matrices used for stem cell culture suffer from severe limitations that impede clinical progress. The most widely used commercial substrates are derived from animal tumors, resulting in a xenogeneic origin and a highly undefined biochemical composition. Consequently, these traditional matrices exhibit significant batch-to-batch variability, making experimental reproducibility incredibly difficult. Furthermore, the presence of unknown animal-derived proteins introduces confounding variables into cellular assays and poses severe immunogenic risks, ultimately hindering the scalability and safe translation of stem cell therapies into human clinical applications.
The synthetic hydrogel system utilizes self-assembling nucleopeptides to form fibrous, extracellular matrix-like networks at physiological pH. As a highly tunable platform, this solution can be complexed with polysaccharides like sodium alginate to enhance structural stability and enable sustained growth factor release. The hydrogel is easily functionalized with bioactive peptide motifs—such as RGD, YIGSR, or IKVAV—to promote cell adhesion and support diverse cell types in 3D culture. Additionally, the system can incorporate and deliver nucleic acids, including pro-survival microRNAs, to regulate gene expression and boost cell viability, creating a defined, biocompatible, and biodegradable substrate.
This technology is differentiated by providing a fully synthetic, biomimetic alternative to traditional animal-derived matrices like Matrigel. Current gold-standard matrices suffer from batch-to-batch variability, xenogeneic origins, and undefined chemical compositions, which hinder experimental reproducibility and clinical translation. By utilizing a modular approach, this solution overcomes these barriers, offering precise customization without compromising the cellular environment. Its defined composition ensures consistent, scalable results, making it uniquely suited for cultivating sensitive human induced pluripotent stem cells. Combining structural tunability, targeted bioactivity, and localized gene delivery within a single, reproducible platform sets it apart from conventional cell culture substrates.
This patent is available for exclusive licensing.
A modular, synthetic hydrogel platform utilizes self-assembling nucleopeptides, like thymine-triphenylalanine, to create fibrous, biomimetic scaffolds at physiological pH. Enhanced by polysaccharides, the system offers tunable mechanical stability and sustained growth factor release. Functionalization with bioactive motifs promotes cell adhesion, while the matrix facilitates nucleic acid delivery for gene regulation. It serves as a biocompatible, biodegradable 3D substrate for advanced human induced pluripotent stem cell culture.
Provisional Patent 64/034,103 filed 04/09/2026